Indication

Paraganglioma

Paraganglioma is a rare neuroendocrine neoplasm that arises from neural crest–derived extra-adrenal chromaffin or non-chromaffin cells within autonomic paraganglia. Read more about Paraganglioma

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Paraganglioma therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Paraganglioma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Paraganglioma.

Paraganglioma is a rare neuroendocrine neoplasm that arises from neural crest–derived extra-adrenal chromaffin or non-chromaffin cells within autonomic paraganglia.

Affecting the sympathetic or parasympathetic nervous systems, these tumors can develop along peripheral nerve and vascular pathways throughout the head, neck, thorax, abdomen, and pelvis.

Parasympathetic paragangliomas, predominantly found in the head and neck, are typically non-secretory and present as slow-growing, locally compressive masses.

Conversely, sympathetic paragangliomas generally arise in the retroperitoneum or pelvis and frequently hypersecrete catecholamines, producing classic manifestations such as episodic hypertension, palpitations, headaches, and diaphoresis.

Although often benign, all paragangliomas possess variable metastatic potential and exhibit a strong association with hereditary cancer susceptibility syndromes, notably involving germline mutations in succinate dehydrogenase subunit genes.

Personalize your experience

Follow Paraganglioma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it